Chandra Goparaju

 ChandraM. Goparaju

Chandra M. Goparaju

  • Courses1
  • Reviews2

Biography

Bergen Community College - Biology


Resume

  • Research

    Immunology

    Molecular Biology

    Science

    Life Sciences

    Genomics

    PCR

    Microbiology

    Cell

    Microsoft Office

    Laboratory

    Genetics

    Biotechnology

    Cancer

    Western Blotting

    Cell Culture

    Biochemistry

    Cell Biology

    Goparaju

    Ph.D.

    Chandra

    Goparaju

    Ph.D.

    Bergen Community College

    NATIONAL HEALTH RESEARCH INSTITUTES

    Aurora Degree College

    Kakatiya University

    Molecular and Structural Endocrinology

    NYU Langone Medical Center

    Columbia University in the City of New York

    Molecular and Structural Endocrinology

    PHD Fellow

    Kakatiya University

    Research Associate

    •\tEstrogens action in the brain: Investigated novel molecular mechanisms of estrogen actions in the brain regions associated with various neuronal disorders such as Alzheimer’s and Parkinson’s diseases

    Ischemic Stroke and depression disorders. \n•\tInvestigated the mechanisms underlying in the synthesis of endogenous 17alpha-estradiol

    a brain derived estrogen and its regulatory action on various genes associated with brain related diseases\n•\tEpigenetics of Tumor Suppressor Genes: Investigated the epigenetic alterations such as SNP’s

    methylation and histone acetylation / deacetylation of various tumor suppressor genes associated with germ cell tumors and cervical cancers. \n•\tDesigned and analyzed gene expression

    genotyping and SNP’s.\n\n

    Columbia University in the City of New York

    NATIONAL HEALTH RESEARCH INSTITUTES

    •\tDrug Discovery & Validation for Cancers: Studied importance of PPAR family genes in cancer drug discovery. Purified and characterized recombinant proteins. Developed cell based ligand-binding assays for the need of high-through put methods for drug-targeted screening.\n•\tStudied the structural and biochemical catalytic properties of DPP IV

    a member of prolyl peptidases family as a validated and effective drug target for the treatment of type II diabetes.\n

    Post doctoral fellow

    Taiwan

    Hanamkonda

    Telagana

    India

    Aurora Degree College

    NYU Langone Medical Center

    New York

    •\tInvestigating Immune biomarker signatures for lung cancer and mesothelioma both in tissue and in the blood for discovery and validation. Conducting research to uncover novel deferentially expressed genes and pathways associated with tumor biology in particularly mesothelioma and lung cancers. \n•\tLead key-clinical translational research initiative in exploring microRNA/mRNA dysregulations

    Next Generation Sequencing

    Epigenomics and identifying novel biomarkers & drug targets for mesothelioma and lung cancers. \n•\tApplying bioinformatics and computational systems biology to basic translational medical research in cancer

    including functional genomics

    experimental design

    hypothesis generation and publication of critical findings with a focus on personalized therapies.\n•\tLeading and managing cross-functional teams of laboratory technicians engaged in large-scale projects and actively participating in large multi-site program project that integrates computer and experimental biologists at centers across the United States

    with a direct role in biomarker discovery and validation in circulating body fluids Mentored and trained laboratory technicians

    post-docs

    resident fellows and summer students.\n•\tDeveloped Multiplex SOMAmer assay for the diagnostic and prognostic cancer biomarkers.\n•\tExploring the gene expression immune-oncology profiles of circulating blood components for the early detection and diagnosis of Lung cancers and mesothelioma: \n•\tExploring circulating microRNA profiling in the blood plasma and exosomes of lung cancers and mesothelioma.\n\n\n\nhttp://www.ncbi.nlm.nih.gov/pubmed/?term=goparaju+c\n\nhttp://www.ncbi.nlm.nih.gov/pubmed/?term=goparju+c\n\nPatents:\n\n12/25/14 - 20140378336 - DIAGNOSIS OF CELL PROLIFERATIVE DISEASE\nInventors: Harvey I. Pass

    Chandra Goparaju \n\nOSTEOPONTIN ISOFORM A INHIBITORS AND METHODS OF USE\nApplication number: 20150004157\nInventors: Harvey I. Pass

    Jessica S. Donington

    Chandra M. Goparaju

    Senior Scientist

    PARAMUS

    NJ

    •\tSince 2017

    as an adjunct

    I have been teaching microbiology for undergraduate students both class room lectures and labs.

    Adjunct Professor

    Department of Biology & Horticulture

    Bergen Community College

    Doctor of Philosophy - PhD

    Environmental Toxiology

    Kakatiya University (University College of Pharmaceutical Sciences)

BIO 104

1.5(2)